64 related articles for article (PubMed ID: 6183928)
21. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
Padrón F; Sanz J; Flórez J
Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
[No Abstract] [Full Text] [Related]
22. [Role of the kidneys in novocainamide pharmacokinetics].
Zverev IaF
Farmakol Toksikol; 1982; 45(6):50-2. PubMed ID: 7152001
[No Abstract] [Full Text] [Related]
23. [Pharmacokinetics and bioequivalence of various oral formulations of metoclopramide].
Vergin H; Bishop-Freudling GB; Strobel K; Reeves DS
Arzneimittelforschung; 1983; 33(3):458-62. PubMed ID: 6683523
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of cardiovascular drugs.
Vlietstra RE
Cardiovasc Clin; 1980; 10(3):255-70. PubMed ID: 6991113
[No Abstract] [Full Text] [Related]
25. Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
Meltzer HY; So R; Fang VS
Adv Biochem Psychopharmacol; 1982; 35():61-82. PubMed ID: 6756062
[No Abstract] [Full Text] [Related]
26. [Bioavailability of metoclopramide with special reference to relevant literature data].
Berner G; Emschermann B; Gladtke E; Haase W; Leuschner F; Vögtle-Junkert U; Wagener HH
Arzneimittelforschung; 1982; 32(2):169-73. PubMed ID: 7199924
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].
Lévy RH; Lévy S; Bricaud H
Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416
[TBL] [Abstract][Full Text] [Related]
28. Absorption of drugs from the skeletal muscle of the rats. 4. Absorption of cationic drugs from the muscle.
Okumura K; Sezaki H; Kakemi K
Chem Pharm Bull (Tokyo); 1972 Aug; 20(8):1607-11. PubMed ID: 4639302
[No Abstract] [Full Text] [Related]
29. [Pharmacokinetic and metabolic aspects of parsalmide in various animal species and man].
Fleischmann L
Boll Chim Farm; 1980 Jul; 119(7):385-90. PubMed ID: 6893933
[No Abstract] [Full Text] [Related]
30. Evaluation of DNA-damaging, clastogenic, and promoting activities of metoclopramide and procainamide in rats.
Mereto E; Robbiano L; Ghia M; Allavena A; Martelli A; Brambilla G
Toxicol Appl Pharmacol; 1995 Apr; 131(2):192-7. PubMed ID: 7716761
[TBL] [Abstract][Full Text] [Related]
31. [Procainamide in renal failure].
Ochotny R; Michałowska D; Lowicki Z; Chmara E
Pol Tyg Lek; 1983 Oct; 38(41):1281-3. PubMed ID: 6672805
[No Abstract] [Full Text] [Related]
32. Lack of interaction between metoclopramide and morphine in vitro and in mice.
Ung D; Cowan A; Parkman HP; Nagar S
Xenobiotica; 2008 Nov; 38(11):1365-76. PubMed ID: 18942041
[TBL] [Abstract][Full Text] [Related]
33. Testing of metoclopramide and procainamide for their ability to induce genotoxic effects in cultured mammalian cells.
Martelli A; Campart GB; Canonero R; Mattioli F; Brambilla G
Toxicol Appl Pharmacol; 1995 Apr; 131(2):185-91. PubMed ID: 7716760
[TBL] [Abstract][Full Text] [Related]
34. The substituted benzamides in gastroenterology.
Nowak TV; Schulze-Delrieu K
Adv Biochem Psychopharmacol; 1982; 35():195-203. PubMed ID: 6756061
[TBL] [Abstract][Full Text] [Related]
35. [Denegyt (R) metabolism in rats and dogs].
Jerkovich G; Elekes I; Lázaŕ-Magyar A; Horváth G
Acta Pharm Hung; 1978; 48 Suppl():26-9. PubMed ID: 749523
[No Abstract] [Full Text] [Related]
36. Proceedings: In vitro metabolism of metoclopramide.
Beckett AH; Huizing G
J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():42P. PubMed ID: 2716
[No Abstract] [Full Text] [Related]
37. Disease states and drug pharmacokinetics.
Koup JR
J Clin Pharmacol; 1989 Aug; 29(8):674-9. PubMed ID: 2674207
[No Abstract] [Full Text] [Related]
38. Pharmacokinetics and metabolism of the benzamides.
Bateman DN
Adv Biochem Psychopharmacol; 1982; 35():143-62. PubMed ID: 6183928
[No Abstract] [Full Text] [Related]
39. [Pharmacokinetics and preliminary evaluation of the anti-arrhythmic effectiveness of N-acetylprocainamide in ventricular disorders of cardiac rhythm].
Ochotny R; Lowicki Z
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1445-7. PubMed ID: 2421273
[No Abstract] [Full Text] [Related]
40. [Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].
Matusewicz W; Orszulak DE
Przegl Lek; 1984; 41(5):379-83. PubMed ID: 6206523
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
